November 15, 2017
The 5 things we learned from Trump’s Asia trip
President Trump returned Tuesday night after 12 days in Asia. So what did we learn from his stops in Japan, South Korea, China, Vietnam and the Philippines? Here are five takeaways:
1) Trump embraced alliances (sort of) but didn’t really reassure anyone
A typical goal of presidential trips is to tend to alliance relations — to maintain and renew ties, provide reassurance where needed or smooth over problems. Given Trump’s long-standing skepticism of alliances, there were significant questions about whether he would reassure anxious allies in Japan and South Korea.
The Japan leg of the trip went reasonably smoothly. Given the close bond Trump has formed with Japanese Prime Minister Shinzo Abe, that’s perhaps unsurprising.
A smooth visit was not a given in South Korea, where relations have been frosty. Since taking office, Trump has called on South Korea to pay for the THAAD missile defense system and has threatened to end the U.S.-ROK free trade deal.
And Trump’s repeated threats to use unilateral force against North Korea are damaging to the U.S.-Korean alliance, forcing the progressive new president, Moon Jae-in, to distance himself from the United States. South Korean public opinion of the U.S. president is at a nadir.
Read the full commentary in the Washington Post.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
